Ikarian Capital »

Upstream Bio shares owned by Ikarian Capital

Quarter-by-quarter ownership of Upstream Bio (UPB) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Upstream Bio

Tip: Access up to 7 years of quarterly data

All positions including Upstream Bio held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Upstream Bio by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.0M 161k 18.81

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Upstream Bio

FMR
OrbiMed Advisors
Decheng Capital
BlackRock
Enavate Sciences GP
Vanguard Group
Bain Capital Life Sciences Investors
TCG Crossover Management
Altshuler Shaham
Omega Fund Management
VR Adviser
Wellington Management Company
State Street Corporation
Samsara BioCapital
Marshall Wace

View all funds holding Upstream Bio